Supranuclear ophthalmoplegia

Supranuclear Ophthalmoplegia is a type of eye movement disorder characterized by the inability to move the eyes in certain directions. This condition arises from a dysfunction in the brain areas that coordinate eye movements, rather than from a problem within the eyes themselves or the nerves directly controlling eye movement. Supranuclear ophthalmoplegia can affect the voluntary control of eye movement while sparing reflexive eye movements, such as those involved in optical tracking.

Causes

Supranuclear ophthalmoplegia is most commonly associated with various neurological conditions. One of the primary diseases linked to this disorder is Progressive Supranuclear Palsy (PSP), a degenerative disease that affects the brain's control of movement. Other conditions that can lead to supranuclear ophthalmoplegia include stroke, multiple sclerosis, and brain tumors. The underlying cause is typically damage or dysfunction in the brain regions responsible for generating the signals that direct eye movement, particularly in the areas known as the supranuclear pathways.

Symptoms

The hallmark symptom of supranuclear ophthalmoplegia is the difficulty in moving the eyes up or down, which is more pronounced in voluntary movements than in reflexive movements. Patients may also experience double vision when trying to focus on objects, difficulty in looking down (which can cause problems with tasks such as reading or descending stairs), and in some cases, difficulty in moving the eyes horizontally. As the condition progresses, it may lead to complete immobility of the eyes in the affected directions.

Diagnosis

Diagnosis of supranuclear ophthalmoplegia involves a comprehensive neurological examination, focusing on the eye movement abnormalities. Imaging tests, such as MRI scans, may be used to identify any underlying conditions affecting the brain. Additionally, doctors may conduct tests to evaluate the function of the eye muscles and nerves.

Treatment

There is currently no cure for supranuclear ophthalmoplegia, and treatment focuses on managing symptoms and improving quality of life. In cases where an underlying condition is identified, treatment of that condition may alleviate some symptoms of supranuclear ophthalmoplegia. Rehabilitation therapies, including physical and occupational therapy, can help patients adapt to their limitations. In some cases, the use of special glasses or prisms may be recommended to help with double vision.

Prognosis

The prognosis for supranuclear ophthalmoplegia varies depending on the underlying cause. In degenerative conditions like PSP, the symptoms may progressively worsen over time. However, with appropriate management and supportive care, many individuals can maintain a good quality of life despite their limitations.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian